Program areas at Brain Chemistry Labs
The Brain Chemistry Labs seeks to discover novel ways of preventing, diagnosing, and treating brain diseases. Our current focus is on progressive neurodegenerative diseases characterized by protein misfolds, including Alzheimers, ALS, Parkinsons, and Lewy Body disease. We are sponsoring a randomized, double-blinded, placebo-controlled Phase II clinical trial of the amino acid L-serine for the treatment of Mild Cognitive Impairment (a precursor of Alzheimers disease) at Houston Methodist Research Institute. We are currently raising funds for advanced clinical trials of L-serine for ALS, and a clinical trial for WY40687, a new drug we have discovered for advanced Parkinsons disease. We have discovered microRNA fingerprints, extracted from extracellular vesicles in the bloodstream, which are diagnostic for ALS as well as a novel metabolite which is diagnostic for early-stage Alzheimers disease. We have also discovered that naturally occurring small proteins, called cyclotides, may be useful as chemotherapy adjuvants for glioblastoma.
Who funds Brain Chemistry Labs
Grants from foundations and other nonprofits
Personnel at Brain Chemistry Labs
| Name | Title | Compensation | Date of data |
|---|
| Paul Alan Cox | Executive Director | $268,718 | 2023-08-17 |
| William C Egan | Chairman | $0 | 2022-12-31 |
| Patrick Henry | Treasurer | $0 | 2022-12-31 |
| John Wetherell | Acting Chair | $0 | 2022-12-31 |
Financials for Brain Chemistry Labs
| Revenues | FYE 12/2023 | FYE 12/2022 | % Change |
|---|
| Total grants, contributions, etc. | $1,916,166 | $1,747,535 | 9.6% |
| Program services | $30,402 | $119,771 | -74.6% |
| Investment income and dividends | $92,581 | $28,551 | 224.3% |
| Tax-exempt bond proceeds | $0 | $0 | - |
| Royalty revenue | $0 | $0 | - |
| Net rental income | $0 | $0 | - |
| Net gain from sale of non-inventory assets | $398 | $-1,426 | 127.9% |
| Net income from fundraising events | $0 | $0 | - |
| Net income from gaming activities | $0 | $0 | - |
| Net income from sales of inventory | $0 | $0 | - |
| Miscellaneous revenues | $0 | $0 | - |
| Total revenues | $2,039,547 | $1,894,431 | 7.7% |
Organizations like Brain Chemistry Labs
| Organization | Type | Location | Revenue |
|---|
| Associated Scientists To Help Minimize Allergies (ASTHMA) | 501(c)(3) | Seattle, WA | $1,011,590 |
| Odylia Therapeutics | 501(c)(3) | Atlanta, GA | $1,098,401 |
| Salisbury Foundation for Research and Education | 501(c)(3) | Salisbury, NC | $553,341 |
| Pacific Health Research and Education Institute | 501(c)(3) | Honolulu, HI | $865,497 |
| Pire California | 501(c)(3) | Berkeley, CA | $1,029,599 |
| Betterhumans | 501(c)(3) | Gainesville, FL | $6,141,222 |
| Vivli | 501(c)(3) | Burlington, MA | $5,206,066 |
| Dreyfus Health Policy and Research Center | 501(c)(3) | Nashville, TN | $1,305,031 |
| Institute for Protein Innovation | 501(c)(3) | Boston, MA | $4,022,792 |
| Haskins Laboratories | 501(c)(3) | New Haven, CT | $4,769,778 |
Data update history
August 25, 2024
Received grants
Identified 11 new grant, including a grant for $100,000 from The Seidler Foundation September 30, 2023
Posted financials
Added Form 990 for fiscal year 2022
Nonprofit Types
Medical research organizationsResearch centersCharities
Issues
Science and technologyHealth
Characteristics
Conducts researchTax deductible donationsAccepts online donations
General information
- Address
- PO Box 3464
- Jackson, WY 83001
- County
- Teton County, WY
- Website URL
- brainchemistrylabs.org/Â
- Phone
- (801) 375-6214
IRS details
- EIN
- 20-1829529
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 2004
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- H00: Medical Research: General
- NAICS code, primary
- 5417: Scientific Research and Development Services
- Parent/child status
- Independent
Free account sign-up
Want updates when Brain Chemistry Labs has new information, or want to find more organizations like Brain Chemistry Labs?
Create free Cause IQ account